Category: Our News

Montreal (Quebec), June 16th, 2022 – CQDM is proud to announce the funding of a project in collaboration with the centre hospitalier universitaire (CHU) de Québec-Université Laval, SPM Therapeutics, and the Fondation du CHU de Québec. The funding, totalling $103,158, was made possible by a grant of $51,847 from the Ministère de l’Économie et de…

Industrial research clusters hail a relevant and ambitious policy Quebec City, May 19, 2022 – The sector-based industrial research clusters (RSRIs), which form critical innovation and technology transfer hubs, welcome the new Quebec Research and Innovation Investment Strategy 2022-2027 (SQRI²) presented today by the Legault government. “This strategy is right on target; one of the…

Montreal, Quebec, May 13, 2022 – CQDM is delighted with the measures announced as part of the updated Quebec Life Sciences Strategy, unveiled yesterday by Minister Fitzgibbon at the Effervescence event. The Strategy has a total budget of $211 million, including $110 million in new funding for the 2022-2025 period. The measures set out in…

ABOUT CQDM  Since its creation, CQDM has raised nearly $190 million to fund the development of approximately 130 drugs addressing major health concerns, including cancer, and neurodegenerative and metabolic diseases. CQDM is a biopharmaceutical research consortium with the socially responsible mission of funding the development of innovative tools and technologies that accelerate the development of safe and…

MONTREAL, April 28 2022 – CQDM is proud to announce the launch of a $5,254,895 project exploring new class of drugs to treat eye pain and blindness. The ministère de l’Économie et de l’Innovation (MEI) will provide $1,268,682 to the project as part of CQDM’s SynergiQC program which, combined with support from public institutions (Mitacs…

Montreal, Quebec, March 10th, 2022 – CQDM is proud to announce the funding of a project in collaboration with the Centre de recherche de l’Hôpital du Sacré-Cœur de Montréal (CIUSSS NIM), NanoGene Therapeutics, the Hôpital du Sacré-Cœur de Montréal Foundation and the Chaire de recherche en orthopédie de l’Université de Montréal. The funding, totalling $333,334,…

Montréal – Québec – March 1st, 2022 – CQDM Is proud to partner with BIOTECanada to present the next Bio+ech Connec+ event taking place on Wednesday, March 16th and featuring Merck.  Bio+ech Connec+, is a unique forum for early-stage Canadian biotech companies to connect directly with the business development and investment leaders of multinational pharma/biotech companies. This virtual…

Montreal, Quebec, January 12, 2022 – CQDM is proud to announce the awarding of a grant in collaboration with McGill University, Neurasic Therapeutics, McGill University’s Healthy Brain, Healthy Life (HBHL) initiative and the Louise and Alan Edwards Foundation. This collaborative research project led by Professor Philippe Séguéla, a world-renowned neuroscientist and pioneer in the identification…

Montreal – December 14, 2021 – CQDM is delighted with Monday’s announcement by Pierre Fitzgibbon, Minister of the Economy and Innovation and Minister responsible for Regional Economic Development, at the Board of Trade of Metropolitan Montreal’s Strategic Forum on the Pharmaceutical Industry. Through the FACS, the Quebec government will provide $35 million in funding for…

MONTREAL, November 30, 2021 – During this Lung Cancer Awareness Month, CQDM is proud to announce that it will co-fund a project driven by Dr Philippe Joubert and Pr. Yohan Bossé at the Quebec Heart and Lung Institute (Institut Universitaire de Cardiologie et Pneumologie du Québec-Université Laval – IUCPQ-UL) targeting a program of early-stage detection…